Literature DB >> 24040480

MMP-2 and DcR3 expression in esophageal cancer tissue and correlation with patient survival.

Ran Ao1, Ya-Qi Du, Ying Wang, Yu-Shuai Chen, Bing-Yuan Wang.   

Abstract

OBJECTIVE: This study aims to explore the expression of decoy receptor 3 (DcR3) and the matrix metalloproteinase-2 (MMP-2) in esophageal carcinoma and their relationship with patient survival.
METHODS: The EnVision(TM) immunohistochemistry method was used to examine DcR3 and MMP-2 expression in 150 surgical biopsies of esophageal carcinoma. Expression level was compared with clinical indices and with patient survival.
RESULTS: In cancer tissues, the positive expression rate of DcR3 and MMP-2 was 54.00% and 54.67% respectively; this was higher than levels in adjacent normal tissue. DcR3 and MMP-2 were positively correlated with carcinoma size, lymphatic metastasis, invasion degree, clinical stage and 3-year survival. DcR3 and MMP-2 were not correlated with gender, age and tumor degree of differentiation. DcR3 and MMP-2 were positively correlated between in the two groups (r = 0.37, P < 0.01). Kaplan-Meier survival curve showed that higher rates of DcR3 and MMP-2 expression correlated with lower survival.
CONCLUSIONS: Determining DcR3 and MMP-2 expression may be useful for the diagnosis, treatment and prognosis of patients with esophageal carcinoma.

Entities:  

Keywords:  Esophageal cancer; decoy receptor; matrix metalloproteinase-2

Year:  2013        PMID: 24040480      PMCID: PMC3762627     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  16 in total

Review 1.  Telomeres and telomerase in cancer.

Authors:  Steven E Artandi; Ronald A DePinho
Journal:  Carcinogenesis       Date:  2009-11-03       Impact factor: 4.944

2.  MMP-2 but not MMP-9 associated with COX-2 and survival in gastric cancer.

Authors:  J Mrena; J-P Wiksten; S Nordling; A Kokkola; A Ristimäki; C Haglund
Journal:  J Clin Pathol       Date:  2006-06       Impact factor: 3.411

3.  Decoy receptor 3 increases monocyte adhesion to endothelial cells via NF-kappa B-dependent up-regulation of intercellular adhesion molecule-1, VCAM-1, and IL-8 expression.

Authors:  Chia-Ron Yang; Shie-Liang Hsieh; Feng-Ming Ho; Wan-Wan Lin
Journal:  J Immunol       Date:  2005-02-01       Impact factor: 5.422

4.  Clinical significance of secreted protein acidic and rich in cystein in esophageal carcinoma and its relation to carcinoma progression.

Authors:  Keishi Yamashita; Sunil Upadhay; Kohshi Mimori; Hiroshi Inoue; Masaki Mori
Journal:  Cancer       Date:  2003-05-15       Impact factor: 6.860

5.  Decoy receptor 3 is a prognostic factor in renal cell cancer.

Authors:  Stephan Macher-Goeppinger; Sebastian Aulmann; Nina Wagener; Benjamin Funke; Katrin E Tagscherer; Axel Haferkamp; Markus Hohenfellner; Sunghee Kim; Frank Autschbach; Peter Schirmacher; Wilfried Roth
Journal:  Neoplasia       Date:  2008-10       Impact factor: 5.715

6.  Decoy receptor 3 overexpression and immunologic tolerance in hepatocellular carcinoma (HCC) development.

Authors:  Caixia Chen; Changgong Zhang; Guohong Zhuang; Hongfang Luo; Jinhua Su; Pinh Yin; Juan Wang
Journal:  Cancer Invest       Date:  2008-12       Impact factor: 2.176

7.  Decoy receptor 3 expressed in rheumatoid synovial fibroblasts protects the cells against Fas-induced apoptosis.

Authors:  Shinya Hayashi; Yasushi Miura; Takayuki Nishiyama; Makoto Mitani; Koji Tateishi; Yoshitada Sakai; Akira Hashiramoto; Masahiro Kurosaka; Shunichi Shiozawa; Minoru Doita
Journal:  Arthritis Rheum       Date:  2007-04

8.  Soluble decoy receptor 3 induces angiogenesis by neutralization of TL1A, a cytokine belonging to tumor necrosis factor superfamily and exhibiting angiostatic action.

Authors:  Chia-Ron Yang; Shie-Liang Hsieh; Che-Ming Teng; Feng-Ming Ho; Wen-Ling Su; Wan-Wan Lin
Journal:  Cancer Res       Date:  2004-02-01       Impact factor: 12.701

9.  MMP-2, MMP-9, VEGF and CA 15.3 in breast cancer.

Authors:  M Quaranta; A Daniele; M Coviello; M T Venneri; I Abbate; M E Caringella; S Di Tardo; R Divella; P Trerotoli; M Di Gennaro; F Schittulli; E Fransvea; G Giannelli
Journal:  Anticancer Res       Date:  2007 Sep-Oct       Impact factor: 2.480

10.  Ascites from epithelial ovarian cancer contain high levels of functional decoy receptor 3 (DcR3) and is associated with platinum resistance.

Authors:  Joseph P Connor; Mildred Felder
Journal:  Gynecol Oncol       Date:  2008-08-23       Impact factor: 5.482

View more
  5 in total

1.  Prognostic and clinicopathological differences of DcR3 in gastrointestinal cancer: evidence from meta-analysis.

Authors:  Jing Tong; Ran Ao; Ying Wang; Bing Chang; Bing-Yuan Wang
Journal:  Int J Clin Exp Med       Date:  2014-09-15

Review 2.  The Role of Decoy Receptor DcR3 in Gastrointestinal Malignancy.

Authors:  Styliani Lagou; Dimitra Grapsa; Nikolaos Syrigos; Georgios Bamias
Journal:  Cancer Diagn Progn       Date:  2022-07-03

3.  DcR3 combined with hematological traits serves as a valuable biomarker for the diagnosis of cancer metastasis.

Authors:  Junxin Li; Ni Xie; Jianhui Yuan; Lvyan Liu; Qiming Zhou; Xiaohu Ren; Qian Chen; Guizhong Zhang; Qingguo Ruan; Youhai H Chen; Xiaochun Wan
Journal:  Oncotarget       Date:  2017-11-20

4.  Anti-apoptosis Effect of Decoy Receptor 3 in Cholangiocarcinoma Cell Line TFK-1.

Authors:  Ying-Chen Xu; Jing Cui; Li-Jun Zhang; Dong-Xin Zhang; Bing-Chen Xing; Xiong-Wei-Ye Huang; Ji-Xiang Wu; Chao-Jie Liang; Guang-Ming Li
Journal:  Chin Med J (Engl)       Date:  2018-01-05       Impact factor: 2.628

5.  Overexpression of DcR3 and its significance on tumor cell differentiation and proliferation in glioma.

Authors:  Suning Huang; Gang Chen; Yiwu Dang; Long-Hua Chen
Journal:  ScientificWorldJournal       Date:  2014-03-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.